Search clinical trials for: Portal vein tumor thrombosis (PVTT)

Total 40038 results

Taiwan Liposome Company

Terminated

A Dose-escalation Study of Lipotecan® Plus Radiotherapy in Locally Advanced Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Taiwan
Ming Zhao

Unknown

Combine TACE and RFA Versus TACE Alone for HCC With PVTT (CORTT)

Hepatocellular Carcinoma

China
RenJi Hospital

Not yet recruiting

IMRT Plus PD-1 Blockade and Lenvatinib for HCC With PVTT (Vp3) Before Liver Transplantation (iPLENTY-pvtt)

Hepatocellular Carcinoma | Liver Transplant; Complications | Liver Cancer | Portal Vein Thrombosis | Radiotherapy; Complications

China
Huazhong University of Science and Technology

Unknown

PD-1 Monoclonal Antibody Plus Apatinib Combined With SBRT in HCC With PVTT

HCC

China
Zhongda Hospital

Completed

ISP-TACE Versus TACE for HCC With PVTT

HCC | Portal Vein Tumor Thrombosis

China
Zhongda Hospital

Unknown

Irradiation Stent Placement Plus TACE for HCC and PVTT

Hepatocellular Carcinoma | Portal Vein Tumor Thrombosis

China
Sun Yat-sen University

Recruiting

Neo-TACE-HAIC for PVTT-HCC (NeoconceptC)

Hepatocellular Carcinoma | Portal Vein Thrombosis

China
Sun Yat-sen University
Second Affiliated Hospital of Guangzhou Medical University

Completed

HAIC Combined With Lenvatinib and Sintilimab for Hepatocellular Carcinoma With PVTT

Carcinoma, Hepatocellular | Liver Neoplasms | Sintilimab | Portal Vein Tumor Thrombus

China
Sun Yat-sen University

Unknown

Toripalimab Plus Stereotactic Body Radiotherapy for HCC With PVTT

Hepatocellular Carcinoma

China
Beijing Ditan Hospital

Enrolling by invitation

Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT

Carcinoma, Hepatocellular | Portal Vein Tumor Thrombus

China
Sun Yat-sen University

Unknown

Hepatic Resection Versus Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma Complicated by Portal Vein Tumor Thrombosis

Hepatocellular Carcinoma With PVTT

China
Li Xiao Wei

Not yet recruiting

HAIC Combine Tislelizumab and Lenvatinib in the Treatment of HCC With Type IV (Vp4) Portal Vein Tumor Thrombus (HAI-TL) (HAI-TL)

Hepatocellular Carcinoma With PVTT

China
Shanghai Zhongshan Hospital

Not yet recruiting

Tislelizumab Combined With IMRT Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

China
First Affiliated Hospital of Zhejiang University

Recruiting

SBRT+TACE+Sorafenib Vs Sorafenib in the Treatment of uHCC With PVTT

Unresectable Hepatocellular Carcinoma | Portal Vein Thrombosis

China
Tongji Hospital

Not yet recruiting

A Study to Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection

Hepatocellular Carcinoma

China
Third Affiliated Hospital, Sun Yat-Sen University
Sun Yat-sen University; Fifth Affiliated Hospital, Sun Yat-Sen University; Second... and other collaborators

Not yet recruiting

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Hepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion | Tumor Thrombus
Guangxi Medical University

Unknown

Study of Folfox4 Chemotherapy Regimen to Prevent Early Postoperative Recurrence for HCC-PVTT Patients

Carcinoma, Hepatocellular
Second Affiliated Hospital of Guangzhou Medical...
First People's Hospital of Foshan; Huizhou Municipal Central Hospital; Zhongshan... and other collaborators

Completed

Lenvatinib Plus DEB-TACE With/Without FOLFOX-HAIC for Large HCC With PVTT

Hepatocellular Carcinoma Non-resectable

China
Fudan University

Unknown

Efficacy of Postoperative Adjuvant Treatments for Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis

Hepatocellular Carcinoma

China
Beijing Tsinghua Chang Gung Hospital

Unknown

Safety and Efficacy of GSMs-TACE Combined With Surgical Resection in the Treatment of Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)

Hepatocellular Carcinoma (HCC) With Type III Portal Vein Tumor Thrombus (PVTT)

China
Peking University

Recruiting

HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT

Hepatocellular Carcinoma | Portal Vein Thrombosis

China
Shanghai Zhongshan Hospital

Unknown

Adjuvant Therapy With Apatinib for HCC Patients With PVTT Who Underwent Radical Resection

Carcinoma, Hepatocellular

China
Yongchang Zhang

Recruiting

Radiotherapy + Sintilimab + Bevacizumab Biosimilar for uHCC With PVTT

Hepatocellular Carcinoma Non-resectable

China
Guangxi Medical University

Unknown

Neoadjuvant Radiotherapy for HCC Involving Type I PVTT

Hepatocellular Carcinoma

China
Cancer Hospital of Guangxi Medical University

Unknown

A Novel Immunotherapy PD-1 Antiboty to Suppress Recurrence of HCC Combined With PVTT After Hepatic Resection

Hepatocellular Carcinoma

China
Sun Yat-sen University

Unknown

HR Combined With FOLFOX4 for HCC With PVTT

Hepatocellular Carcinoma
Sun Yat-sen University

Recruiting

The Impact on Survival of Neo-adjuvant Transarterial Chemoinfusion (TAI) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) Who Underwent Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Hepatocellular Carcinoma

China
Yongyi Zeng

Not yet recruiting

Neoadjuvant IMRT Combined With Camrelizumab and Apatinib for Resectable HCC With PVTT

Hepatocellular Carcinoma
Second Affiliated Hospital of Guangzhou Medical...

Recruiting

TACE Plus Multikinase Inhibitor and I-125 Seeds Brachytherapy for HCC With Branch PVTT

Hepatocellular Carcinoma Non-resectable

China
Sun Yat-sen University

Recruiting

The Impact on Recurrence Risk of Adjuvant Transarterial Chemoinfusion (TAI) Versus Adjuvant Transarterial Chemoembolization (TACE) for Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombosis (PVTT) After Hepatectomy : A Random, Controlled, Stage III Clinical Trial.

Hepatocellular Carcinoma

China
Jia Fan

Recruiting

A Study to Evaluate Efficacy and Safety of Hepatic Resection for Liver Cancer With PVTT, HVTT or IVCTT After Initial Ate/Bev

Venous Thrombosis

China
Chen Xiaoping

Recruiting

Comparing the Prognosis of Patients With HCC and PVTT Treated With Surgery Versus Locoregional Therapy.

Hepatocellular Carcinoma

China
Sun Yat-sen University

Withdrawn

Safety and Efficacy of Radiation Plus TACE and Lenvatinib in Advanced HCC With PVTT

Advanced Hepatocellular Carcinoma

China
Cancer Institute and Hospital, Chinese Academy...

Recruiting

Phase III RCT of Radiotherapy Plus Toripalimab Versus Sorafenib in Advanced Hepatocellular Carcinoma With PVTT

Advanced Hepatocellular Carcinoma | Radiotherapy | Sorafenib | Toripalimab

China
Yunfei Yuan

Completed

TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone for Hepatocellular Carcinoma With PVTT

Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

HAIC Plus Toripalimab vs. HAIC Plus Sorafenib for HCC With PVTT: a Non-comparative, Prospective, Randomized Trial

Hepatocellular Carcinoma

China
Beijing Tsinghua Chang Gung Hospital

Recruiting

Safety and Efficacy of Lenvatinib and Anti-PD1 Antibody Combined With Radiotherapy Neoadjuvant Treatment for Resectable Hepatocellular Carcinoma With PVTT

Hepatocellular Carcinoma

China
Sun Yat-sen University

Recruiting

Perioperative Sintilimab Plus Bevacizumab Biosimilar and TACE-HAIC for HCC Patients With PVTT: A Phase-2 Clinical Trial

Hepatocellular Carcinoma

China
Seoul National University Hospital

Recruiting

Ablative Radioembolization as a Spearhead Treatment for Locally Advanced Hepatocellular Carcinoma (RESOLVE)

Hepatocellular Carcinoma

Korea, Republic of
First Affiliated Hospital of Guangxi Medical University

Recruiting

Efficacy and Safety of SBRT Combined With Cardonilizumab and Lenvastinib in the Treatment of Unresectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus

Hepatocellular Carcinoma Non-resectable | Immune Checkpoint Inhibitors | Portal Vein Tumor Thrombus

China
Asan Medical Center
Seoul National University Hospital; Hanyang University; Soon Chun Hyang University

Recruiting

Atezolizumab Plus Bevacizumab Alone or Combined With External Beam Radiotherapy for HCC With Macrovascular Invasion (ALERT-HCC)

Hepatocellular Carcinoma | Liver Cancer | Hepatocellular Carcinoma Non-resectable | Hepatocellular Cancer | Hepatocellular Carcinoma Stage IV

Korea, Republic of
Ontario Clinical Oncology Group (OCOG)
Hoffmann-La Roche

Recruiting

Neoadjuvant Combination of Atezolizumab/Bevacizumab Versus Neoadjuvant Radiation Therapy (ADVANCE HCC)

Hepatocellular Carcinoma | Portal Vein Tumour Thrombosis

Canada
Shanghai Zhongshan Hospital
Shanghai Henlius Biotech

Not yet recruiting

Combination Therapy of HAIC and HLX10 and HLX04 in HCC With Major Portal Vein Tumor Thrombosis

Hepatocellular Carcinoma With Major Portal Vein Thrombosis
Poitiers University Hospital

Not yet recruiting

Portal Vein Thrombosis Associated With Unresectable Pancreatic Cancers : a Prospective Multicentric Cohort Study (THROMPAN)

Pancreatic Adenocarcinoma
RenJi Hospital

Not yet recruiting

Lenvatinib Following Liver Transplantation in Patients of Hepatocellular Carcinoma With Portal Vein Tumor Thrombus (LLTHVV)

Liver Transplantation | Hepatocellular Carcinoma | Portal Vein Tumor Thrombus
Hospital Sirio-Libanes

Terminated

Prognostic Value Related to the Presence of Thrombosis or Portal Vein Invasion in Patients With Hepatocellular Carcinoma Submitted to Surgery (HSL2012-06)

Hepatocellular Carcinoma | Hepatic Portal Vein Tumor Invasion | Portal Vein Thrombosis

Brazil
Samsung Medical Center

Completed

Proton Beam Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PTHP)

Liver Neoplasm | Proton Therapy | Portal Vein Tumor Thrombosis

Korea, Republic of
Keimyung University Dongsan Medical Center

Completed

Surgical Outcome of HCC With Portal Vein Tumor Thrombosis on the Basis of Risk Scoring

Hepatocellular Carcinoma | Portal Vein Thrombosis | Prognosis

Korea, Republic of
Second Affiliated Hospital of Guangzhou Medical...
Sun Yat-sen University; Guangdong Provincial People's Hospital; Third Affiliated... and other collaborators

Active, not recruiting

TACE Combined With Iodine-125 Seeds Implantation for HCC

Hepatocellular Carcinoma | Portal Vein Occlusion | Tumor Thrombus

China
Peking University

Completed

Sorafenib Plus Hepatic Arterial Infusion Versus Sorafenib for HCC With Major Portal Vein Tumor Thrombosis

Portal Vein Thrombosis | HepatoCellular Carcinoma

China

Search clinical trials for: Portal vein tumor thrombosis (PVTT)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mauritania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations